Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109


Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation.

Kittlesen DJ, Chianese-Bullock KA, Yao ZQ, Braciale TJ, Hahn YS.

J Clin Invest. 2000 Nov;106(10):1239-49.


Hepatitis C virus: immunosuppression by complement regulatory pathway.

Yao ZQ, Ray S, Eisen-Vandervelde A, Waggoner S, Hahn YS.

Viral Immunol. 2001;14(4):277-95. Review.


Direct binding of hepatitis C virus core to gC1qR on CD4+ and CD8+ T cells leads to impaired activation of Lck and Akt.

Yao ZQ, Eisen-Vandervelde A, Waggoner SN, Cale EM, Hahn YS.

J Virol. 2004 Jun;78(12):6409-19. Erratum in: J Virol. 2007 Apr;81(7):3673.


gC1qR expression in chimpanzees with resolved and chronic infection: potential role of HCV core/gC1qR-mediated T cell suppression in the outcome of HCV infection.

Yao ZQ, Shata MT, Tricoche N, Shan MM, Brotman B, Pfahler W, Hahn YS, Prince AM.

Virology. 2006 Mar 15;346(2):324-37. Epub 2005 Dec 20. Retraction in: Virology. 2007 Nov 25;368(2):432.


T cell dysfunction by hepatitis C virus core protein involves PD-1/PDL-1 signaling.

Yao ZQ, King E, Prayther D, Yin D, Moorman J.

Viral Immunol. 2007 Summer;20(2):276-87.


Differential regulation of SOCS-1 signalling in B and T lymphocytes by hepatitis C virus core protein.

Yao ZQ, Prayther D, Trabue C, Dong ZP, Moorman J.

Immunology. 2008 Oct;125(2):197-207. doi: 10.1111/j.1365-2567.2008.02829.x. Epub 2008 Apr 4.


Identification of the gC1qR sites for the HIV-1 viral envelope protein gp41 and the HCV core protein: Implications in viral-specific pathogenesis and therapy.

Pednekar L, Valentino A, Ji Y, Tumma N, Valentino C, Kadoor A, Hosszu KK, Ramadass M, Kew RR, Kishore U, Peerschke EI, Ghebrehiwet B.

Mol Immunol. 2016 Jun;74:18-26. doi: 10.1016/j.molimm.2016.03.016. Epub 2016 Apr 23.


Expression and immune response to hepatitis C virus core DNA-based vaccine constructs.

Tokushige K, Wakita T, Pachuk C, Moradpour D, Weiner DB, Zurawski VR Jr, Wands JR.

Hepatology. 1996 Jul;24(1):14-20.


HCV core protein binds to gC1qR to induce A20 expression and inhibit cytokine production through MAPKs and NF-κB signaling pathways.

Song X, Yao Z, Yang J, Zhang Z, Deng Y, Li M, Ma C, Yang L, Gao X, Li W, Liu J, Wei L.

Oncotarget. 2016 Jun 7;7(23):33796-808. doi: 10.18632/oncotarget.9304.


The binding protein for globular heads of complement C1q, gC1qR. Functional expression and characterization as a novel vitronectin binding factor.

Lim BL, Reid KB, Ghebrehiwet B, Peerschke EI, Leigh LA, Preissner KT.

J Biol Chem. 1996 Oct 25;271(43):26739-44.


Role of the receptor for the globular domain of C1q protein in the pathogenesis of hepatitis C virus-related cryoglobulin vascular damage.

Sansonno D, Tucci FA, Ghebrehiwet B, Lauletta G, Peerschke EI, Conteduca V, Russi S, Gatti P, Sansonno L, Dammacco F.

J Immunol. 2009 Nov 1;183(9):6013-20. doi: 10.4049/jimmunol.0902038. Epub 2009 Oct 14.


Tim-3 negatively regulates IL-12 expression by monocytes in HCV infection.

Zhang Y, Ma CJ, Wang JM, Ji XJ, Wu XY, Jia ZS, Moorman JP, Yao ZQ.

PLoS One. 2011;6(5):e19664. doi: 10.1371/journal.pone.0019664. Epub 2011 May 26.


The multiligand-binding protein gC1qR, putative C1q receptor, is a mitochondrial protein.

Dedio J, Jahnen-Dechent W, Bachmann M, Müller-Esterl W.

J Immunol. 1998 Apr 1;160(7):3534-42.


Frequency of gC1qR+CD4+ T cells increases during acute hepatitis C virus infection and remains elevated in patients with chronic infection.

Cummings KL, Rosen HR, Hahn YS.

Clin Immunol. 2009 Sep;132(3):401-11. doi: 10.1016/j.clim.2009.05.002. Epub 2009 May 26.


gC1q-R/p33, a member of a new class of multifunctional and multicompartmental cellular proteins, is involved in inflammation and infection.

Ghebrehiwet B, Lim BL, Kumar R, Feng X, Peerschke EI.

Immunol Rev. 2001 Apr;180:65-77. Review.


Supplemental Content

Support Center